High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
MIMETAS Address
De Limes 7 Leiden, null Netherlands
MIMETAS Email
Past Companies
MIMETASPrincipal Scientist
MIMETAS - The Organ on a Chip CompanySenior Scientist
Perelman School of Medicine at the University of PennsylvaniaPostdoctoral Fellow